🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Disc Medicine, Inc.

IRON Healthcare
$75.14 $-0.97 (-1.27%)
Market Cap: $3.42 B
Gurus Holding
4
Popularity Rank
#2459
% of Shares Held
0.26%
Net Activity (Q3 2026)
+$1.33 M

Guru Ownership Trend

Guru Analysis for Disc Medicine, Inc. (IRON)

Disc Medicine, Inc. (IRON), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.76 M.

Top institutional holders include Louis Moore Bacon and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $1.33 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 12.8%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$1.47 M
Total Buy Value
New Buys 1
Additions 1
-$135,960.17
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Disc Medicine, Inc. (IRON)

Major holders include Louis Moore Bacon ($4.54 M), Paul Tudor Jones ($1.82 M), Jefferies Group ($706,641). According to the latest reported data, 4 tracked investment managers collectively hold approximately 116,637 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.33 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited IRON. The total reported sell value was $135,960.17.

Yes, 1 managers opened new positions in IRON, and 1 increased their existing holdings. The total reported buy value was $1.47 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.09% Add 20.1% 69,388 $4.54 M Q3 2026
0.00% Reduce -2.9% 27,846 $1.82 M Q3 2026
0.01% New Buy 10,795 $706,641 Q3 2026
0.00% Reduce -12.8% 8,608 $563,478 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form